NEW YORK, Dec. 18, 2017 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Royal Caribbean Cruises Ltd. ("Royal Caribbean" or the "Company") (NYSE: RCL). Such investors are advised to contact Robert S. Willoughby at email@example.com or 888-476-6529, ext. 9980.
The investigation concerns whether Royal Caribbean and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
On December 5, 2017, media outlets reported an outbreak of more than 200 cases of gastrointestinal illness among passengers aboard Royal Caribbean's vessel Ovation of the Seas during a 14-night voyage. On this news, Royal Caribbean's share price fell $2.26, or 1.81%, to close at $122.82 on December 5, 2017.
On December 16, 2017, media outlets reported more than 200 cases of gastrointestinal illness among passengers aboard Royal Caribbean's vessel Independence of the Seas during a 5-night voyage.
The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.
Robert S. Willoughby
SOURCE Pomerantz LLP